178 results on '"Robinson, Murray"'
Search Results
2. The 'Maranui' tragedy of 1968
3. The wind-assisted 'Wingatui'
4. 'Wahine' - a fortieth anniversary look-back
5. My godfather was a sea captain
6. Patient records on computer
7. The burden of Legionnaires' disease in New Zealand (LegiNZ): a national surveillance study
8. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
9. Data from De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model
10. Supplementary Figure 1, Table 1 from De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model
11. Preferential Maintenance of Critically Short Telomeres in Mammalian Cells Heterozygous for mTert
12. A Mammalian Telomerase-Associated Protein
13. Variations in extractive compounds during hydrothermal treatment of lignocellulosic sludge
14. DNA Repair Pathways : Mechanisms and Defects in the Maintenance of Genome Stability
15. Transformation and removal of wood extractives from pulp mill sludge using wet oxidation and thermal hydrolysis
16. Upgrading TMP Whitewater for Internal Recycle: Biological and Physicochemical Treatment and Effects on Pulp Quality
17. Telomerase and Cancer
18. Dissecting Genetic Requirements of Human Breast Tumorigenesis in a Tissue Transgenic Model of Human Breast Cancer in Mice
19. Inhibition of Megakaryocyte Differentiation in Vivo by E2F-1
20. Young people’s Perception of Group Climate in Juvenile Justice Centers in an Australian State, a Pilot Study
21. The tsA58 Simian Virus 40 Large Tumor Antigen Disrupts Megakaryocyte Differentiation in Transgenic Mice
22. Transcriptional Regulatory Regions of Testis-Specific PGK2 Defined in Transgenic Mice
23. Young people's Perception of Group Climate in Juvenile Justice Centers in an Australian State, a Pilot Study.
24. Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
25. Chimeric mouse tumor models reveal differences in pathway activation between ERBB family– and KRAS-dependent lung adenocarcinomas
26. Telomere dysfunction: multiple paths to the same end
27. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
28. Principles of Molecular Oncology
29. A telomerase enzymatic assay that does not use polymerase chain reaction, radioactivity, or electrophoresis
30. Cervical Spinal Canal Plasticity in Children as Determined by the Vertebral Body Ratio Technique
31. Gene networks in cardiac hypertrophy and cardiovascular disease GWAS data
32. DNA Repair Pathways: Mechanisms and Defects in the Maintenance of Genome Stability
33. Relationship of hypoxia signature with variant subgroup of clear cell renal cell carcinoma (ccRCC) and its association with clinical activity on tivozanib hydrochloride.
34. Abstract A5: Tivozanib, a selective VEGFR TKI, potently blocks angiogenesis and growth in tumors that express a high level of VEGF-C and are refractory to VEGF-A blockade.
35. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress
36. Abstract 5063: Preclinical evaluation of an EMT multi-gene biomarker index for predicting response to inhibitors of EGFR and IGF1R
37. Abstract 1631: Tumorigenicity of IGF-1R and IR: Rationale for co-targeting IGF-1R and IR in cancer
38. Abstract 1727: Preclinical evaluation of pan-VEGFR inhibitor tivozanib in combination with capecitabine, sirolimus or erlotinib in genetically engineered tumor models support combinations based on complementary mechanisms
39. Population-based engineered tumor models as a platform for biomarker discovery in cancer
40. Abstract 3267: Human population based engineered breast tumor model for in vivo biomarker discovery
41. Abstract 646: Identification of FURIN as a tumor maintenance gene in solid tumors by in vivo Retroviral Mutagenesis and Directed Complementation
42. Abstract 2000: Biological function annotation of microarray data using correlated gene indices
43. Abstract 1378: Preclinical efficacy of the triple VEGFR inhibitor tivozanib (AV-951) in chimeric breast and lung tumor models
44. Abstract A22: Response to the triple VEGFR inhibitor tivozanib (AV‐951) in KRAS and EGFR driven lung tumors developed in chimeric mouse models
45. Abstract B143: Distinct antitumor mechanisms of VEGFR inhibitor tivozanib (AV‐951) and mTOR inhibitor rapamycin support rational combination for solid tumors to overcome drug resistance
46. Abstract B18: Variation in response to VEGFR inhibitor tivozanib in a unique population‐based tumor model enables the development of a multigene response biomarker
47. Abstract A233: Generation ofin vitroandin vivotumor models driven by insulin‐like growth factor receptor (IGF1R) and their use in the development of OSI‐906, a selective IGF1R inhibitor
48. Abstract A12: Variation in response to triple VEGFR inhibitor tivozanib in mouse models of hepatocellular carcinoma
49. Abstract A255: Activity of VEGFR inhibitor tivozanib as a single agent or in combination with EGFR inhibitor erlotinib in engineered lung adenocarcinoma models
50. De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.